A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

Optimizing urate-lowering therapy to achieve target serum urate levels may not harm, and may benefit ... absolute risk and an 11% lower relative risk of kidney function decline to an estimated ...

This week Novartis NVS upgraded its mid-term sales growth guidance. The European Commission approved Pfizer’s PFE hemophilia ...

Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

When complex multicellular organisms grow and develop, their tissues must undergo remodeling. As new cells begin to ...